![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2008 by The National Academy of Sciences of the USA Neuroscience Dividing glial cells maintain differentiated properties including complex morphology and functional synapses aHoward Hughes Medical Institute and Departments of Physiology and Biochemistry, University of California, San Francisco, CA 94158; and bBritton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430074, China. 1To whom correspondence should be addressed. E-mail: yuhnung.jan/at/ucsf.edu Contributed by Yuh Nung Jan, November 8, 2008 .Author contributions: W.-P.G. designed research; W.-P.G. and W.Z. performed research; W.-P.G., W.Z., and Q.L. analyzed data; and W.-P.G., L.Y.J., and Y.N.J. wrote the paper. Received October 13, 2008. Freely available online through the PNAS open access option. Abstract It is generally believed that dividing cells gain complex features of differentiation only after exiting the cell cycle because cell division and differentiation are both under such tight regulation that their coexistence is deemed unlikely. As the major proliferating cell type in the mammalian CNS, NG2 glial cells (NG2 cells) account for 5–8% of the glial cell population and form synaptic contacts with neurons. Here we report that NG2 cells divide while maintaining their differentiation, including morphological features, such as the elaboration of multiple complex cellular processes and physiological features including active glutamatergic and GABAergic synaptic responses. Not only do NG2 cells continue to receive excitatory and inhibitory synaptic inputs as they undergo mitosis, a subpopulation of dividing NG2 cells can fire action potentials upon depolarization, thereby revealing that these dividing NG2 cells retain voltage-gated ion channels as well as transmitter receptors for signal processing. These findings provide a clear counterexample of the widely perceived incompatibility between cell division and differentiation. Keywords: action potential, differentiation, NG2 cells, proliferation, mitosis Glial cells constitute 90% of the cells in our brain and have been classified as astrocytes, oligodendrocytes, and microglia (1). NG2 glial cells (NG2 cells), previously known as “protoplasmic” astrocytes on the basis of their morphology in the adult CNS (2), have also been described as oligodendrocyte-type-2 astrocytes (O2A) (3), oligodendrocyte precursor cells (4), “complex glia” (5), or polydendrocytes (6). NG2 cells are the only glial cells that express the chondroitin sulfate proteoglycan NG2, which not only provides the namesake but also serves as a cell marker for NG2 cells (2, 7). Whereas some NG2-expressing cells can generate oligodendrocytes and astrocytes at early developmental stages in vivo (8), there are many NG2 cells in the adult brain after the completion of myelination (4). Moreover, NG2 expression in the adult brain does not overlap with the expression of markers for other glial cell types (9) nor do NG2 cells express immature cell markers including nestin and DCX. Importantly, NG2 cells receive synaptic inputs from neurons (10–14), and the neuron-NG2 glia synapses can undergo activity-dependent modification analogous to long-term potentiation (11), a hallmark of the cellular mechanism underlying learning and memory (15). NG2 cells also make contact with nodes of Ranvier (16) in the white matter and hence are capable of responding to or modulating neuronal activity in a manner perhaps similar to the function of astrocytes (17). Given the unique morphological, physiological, and functional properties of NG2 cells, which are widely distributed in the adult brain, they are now recognized as a distinct, differentiated, macroglial cell population (18, 19). NG2 cells retain the ability to proliferate throughout life (9). They represent the main population of dividing cells and account for ≈70% of BrdU incorporating cells in the adult CNS (9, 20). The propensity for cell division of NG2 cells, which display highly differentiated morphological and electrophysiological features that are suggestive of functional significance in the adult brain, presents an opportunity to examine whether any of the features of NG2 cell differentiation is retained during cell division. The generally perceived incompatibility between differentiation and proliferation has recently been challenged. Ajioka et al. (21) found that cancer cells derived from horizontal interneurons via inactivation of Rb and p130 proliferate while maintaining neurites and synapses characteristic of differentiated neurons, thus revealing that, at least under pathological conditions, proliferating cells may remain differentiated. To test whether proliferation could be compatible with differentiation of normal cell types, we examined NG2 cells in healthy brains of adult rodents and tested the hypothesis that these cells can enter the cell cycle while maintaining their highly differentiated features, including complex cell morphology and synaptic inputs. Results NG2 Cells Divide While Retaining Differentiated Morphology. NG2 cells in the rodent brain are known to retain the ability to proliferate throughout the postnatal life (4). Indeed, when cell proliferation was examined by BrdU incorporation in mouse brains double-labeled with the antibody against BrdU and antibody specific for NG2 cells, we found BrdU+NG2+ cells in 3-week-old to 5-month-old mice (Fig. 1
The NG2 cell morphological differentiation is characterized by the presence of multiple thin, branched processes extending radically from the cell body (Fig. S1). What happens to these processes when a NG2 cell enters the cell cycle? To address this question, we used BrdU to label dividing cells. BrdU is incorporated into newly synthesized DNA during the S phase of the cell cycle and is included in the DNA thereafter. Thus, after BrdU pulse labeling, the BrdU+ cells include those cells in S, G2, and M phase each with a single BrdU+ nucleus, and the daughter cells shortly after exit of the cell cycle, thus giving the appearance of pairs of adjacent BrdU+ nuclei (24). We found that almost all of the BrdU+NG2+ cells appeared as isolated individual cells with multiprocess morphology 2 h after the first BrdU injection (98.9%, 90 of 91 cells) (Fig. 1 To examine the cellular morphology during mitosis, we used DAPI to mark the DNA, thereby rendering those cells at metaphase (Fig. 1 To determine whether NG2 cells can maintain their complex processes during division rather than having to retract then regrow them, we used time-lapse microscopy to monitor the division of a cell loaded via the whole-cell patch-clamp electrode with Alexa Fluor 568/594 dyes, which allowed visualization of very thin processes emanating from the cell body in the acute brain slice (26). NG2 cells can be identified based on their distinct electrophysiological properties as described previously (11, 26). In some of the experiments (see Figs. 3
A Subpopulation of Dividing NG2 Cells Can Generate Action Potentials. Action potential has long been considered the unique feature of neurons and other excitable cells, such as cardiac myocytes, although one class of NG2 cells can generate action potentials (27, 28). In the visual cortex, we found that one-third of the nondividing NG2 cells (5 of 15 cells, P9–P11) can fire action potentials (Fig. 3 Dividing NG2 Cells Receive Functional Synaptic Inputs. NG2 cells in several brain regions receive synaptic inputs from neurons (10–14). To determine whether dividing NG2 cells still respond to synaptic inputs, we recorded dividing NG2 cells while stimulating nerve fibers ≈150 μm from the dividing cell via a bipolar stimulating electrode. In the presence of the GABAA receptor antagonist bicuculline (10 μM), evoked excitatory postsynaptic currents (EPSCs) were detected in ≈86% (12 of 14) of the dividing NG2 cells. The EPSCs were eliminated by the AMPA receptor (AMPAR) antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (10 μM, n = 3) (Fig. 4 Given that both glutamatergic and GABAergic synapses have been found in nondividing NG2 cells (29), the attempt was made to record GABAergic synaptic responses by using high KCl-based recording solutions ([Cl−]o = 130 mM; ECl− = ≈1 mV). In the presence of CNQX (10 μM), GABAergic responses were observed in dividing cells (n = 3) and could be blocked by bicuculline (10 μM) (data not shown), in agreement with a recent report (30). Remarkably, spontaneous synaptic responses could be recorded in some dividing NG2 cells (9.9%, 8 of 81 cells; [Cl−]o = 15 mM, ECl− = −55mV). Spontaneous postsynaptic currents were observed at different mitotic stages of NG2 cells including prometaphase (n = 1), metaphase (n = 4), and telophase (n = 3). The currents had rapid rise and decay time (606 ± 56 μs to rise from 10% to 90% peak amplitude; decay time constant, 1.34 ± 0.18 ms; average peak amplitude, 25.3 ± 2.1 pA, n = 8 cells) (Fig. 4 A Subpopulation of NG2 Cells Divide Symmetrically. NG2 cells can divide asymmetrically after injury or while these cells are maintained in a culture (25, 31). To examine the pattern of NG2 cell division in brain slices, the morphological and electrophysiological properties of both daughter cells were compared at or shortly after late-telophase/cytokinesis. After 8 h of pulse-labeling with BrdU, about one-third of the dividing NG2 cells appeared as pairs of daughter cells (n = 58/161). These pairs of BrdU+NG2+ cells shared similar morphology with respect to the size and the number of processes (Fig. 1 Discussion This study demonstrates that, under normal condition in the brain from 9-day to 20 week-old adult mice, highly differentiated glial cells with multiple, branched processes and functional synapses can enter the cell cycle and undergo cell division without losing these features of differentiation. Moreover, dividing NG2 cells still maintain their intrinsic excitability during proliferation. The study further shows that NG2 cells can divide symmetrically yielding 2 daughter cells with similar electrophysiological properties. A recent report (30) documented similar symmetric division of NG2 cells while exhibiting inhibitory synaptic responses in mice 7–12 days after birth. Whereas this phenomenon in young mice suggests that maintaining synaptic inputs during division may facilitate colonization and myelination of the developing brain (30), this study shows that NG2 cells in the adult brain still retain morphological and physiological differentiation during mitosis. These findings provide a counterexample to the notion that cell division is incompatible with differentiation. It is generally believed that cell division and differentiation are not mutually compatible because differentiated cells typically undergo apoptosis when they are forced to enter the cell cycle (32). Before differentiated cells reenter the cell cycle, they typically undergo cellular, molecular, and morphological dedifferentiation (33). However, recent studies reveal that differentiation and proliferation are compatible in cancer cells derived from misregulated interneurons (21), in NG2 cells in the developing brain (30), as well as NG2 cells in the adult brain, as shown in our study. This surprising finding has interesting implications in health and in disease. Gliomas are thought to arise from either preexisting neural stem cells in the adult brain or proliferating cells that are dedifferentiated from glial cell types, such as astrocytes or oligodendrocytes due to oncogenic mutations (34). It remains to be elucidated as to how abnormalities in the cell cycle or other cellular processes might trigger glial transformation for gliomagenesis. This study's finding that NG2 cells proliferate while retaining their differentiated properties raises the question of whether these cells may be transformed to oligodendrogliomas or astrocytomas without dedifferentiation because they lose control of cell cycle regulation. Synaptic Input Function in NG2 Cell Proliferation. The electrical activity is important for immature NG2 cell proliferation during development (35) because neurons can release growth factors including neuregulins (NRGs), which are responsible for the proliferation of NG2 cells (36). After transection of developing optic nerves or intraocular injection of tetrodotoxin (TTX) to block neuronal activity, proliferation of NG2 cells decrease by 90% (35). Maintenance of differentiated properties including synaptic connections with neurons during division allows NG2 cells to continuously sense neuronal signals, which may be important for NG2 cells to retain the proliferation capability throughout life. Synaptic connections between neurons and NG2 cells have been found in both gray matter and white matter (10–14); however, direct evidence on the functional significance of synaptic inputs to NG2 cells is still lacking. Consistent with the presence of calcium-permeable GluR2-lacking AMPARs in NG2 cells (10, 11), activation of the AMPARs mediates calcium influx during synaptic transmission or glutamate application (11, 17). Calcium elevation plays a critical role in the long-term synaptic plasticity of synapses formed between neurons and glia (11) and in glial proliferation, growth, and differentiation (37). In this study, we found that the great majority of dividing NG2 cells display some form of excitability indicative of functional voltage-gated ion channels, with ≈20% of these dividing NG2 cells firing all-or-none action potentials on depolarization. With depolarization induced by synaptic activation, the dividing NG2 cells may fire action potentials in vivo (28), resulting in activation of voltage-gated calcium channels. Calcium influx from AMPARs or voltage-gated calcium channels may contribute to signaling, including the regulation of gene expression that controls the proliferation of NG2 cells. Symmetric Versus Asymmetric NG2 Cell Division. There are 2 types of cell division: symmetric and asymmetric (38). During asymmetric division, the 2 daughter cells acquire a different fate. NG2 cells can divide symmetrically or asymmetrically in vitro (31, 39). According to experiments involving retroviral infection, BrdU tracing, or a Pdgfra-CreER(T2)/Rosa26-YFP double-transgenic line, a small proportion of cycling NG2 cells can give rise to oligodendrocytes over a period of 10 days to 8 months (9, 40, 41). This observation suggests that a low percentage of proliferating NG2 cells undergo asymmetric division in vivo, although more direct evidence is still lacking for NG2 cell asymmetrical division in the normal adult brain. In our 8-h BrdU tracing experiment, we did not find any pair of BrdU-containing NG2 cells with unipolar or bipolar morphology as described in the NG2 cell division model under injury (25). We found that the 2 daughter cells in cytokinesis share similar morphology and similar electrophysiological properties, including sodium current (INa), transient potassium current (IA), delay rectifying potassium current (IK), and synaptic responses. Due to the technical difficulty of this experiment, we obtained only limited data from 11 pairs of daughter cells. Hence, we cannot exclude the possibility that a low percentage of dividing cells undergo asymmetric division. Because we could only record from the daughter cells right after their exit from the cell cycle, we also cannot be certain whether these daughter cells will change their properties later. Methods BrdU Tracing and Immunocytochemistry. For BrdU labeling, mice were injected i.p. with BrdU at 100 μg per gram of body weight (Sigma) twice at 0 and 1 h and killed by perfusion with 4% paraformaldehyde in 1× PBS at 2 h or 8 h after the first BrdU injection. Brains were cut into 15- to 60-μm-think sections with a cryostat (model CM3050S; Leica). To detect BrdU, sections were pretreated with 2 M HCl at 37 °C for 30 min and neutralized in 0.1 M sodium borate buffer, pH 8.5. Sections were permeabilized with 0.5% Triton X-100 in 1× PBS and then blocked by 5% BSA (Sigma) and 3% normal goat serum (Jackson ImmunoResearch) with 0.2% Triton X-100 in 1× PBS. Primary antibodies for BrdU (1:200, monoclonal; Roche), NG2 (1:300, Rabbit anti-NG2, ployclonal; Millipore), or Ki67 (1:200, mouse anti-Ki67; BD PharMingen) were diluted with 0.2% Triton X-100 in 1× PBS and applied to sections, alone or in combination, and allowed to incubate for 48 h at 4 °C. Secondary antibodies conjugated with Alexa Fluor 568 or 488 (1:800; Invitrogen) were used. DAPI was introduced to stain the nuclei. Sections were mounted on slides and covered with coverslips by using the antifade mounting medium Fluoromount G (Southern Biotech). Slice Preparation. Slices were prepared as described previously (11, 42). The use and care of animals follows the guidelines of the Institutional Animal Care and Use Committee at University of California, San Francisco. In brief, mice (C57BL/6; P9–P18, except otherwise noted) were anesthetized with isoflurane (1%–5%). After decapitation, the whole brain was dissected rapidly and placed in an ice-cold oxygenated (95% O2 and 5% CO2) solution containing 119 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl2, 1.3 mM MgSO4, 1 mM NaH2Po4, 26.2 mM NaHCO3, and 11 mM glucose. Transverse slices (300 μm thick) were cut with a vibratome (model VT-1000S; Leica) and maintained in an incubation chamber for at least 1 h at room temperature (RT; 22–25°C) before loading or recording. For K+ current recordings, 1 μM TTX was added to the above solution. Solution for Na+ current recording (only in Fig. 5 Electrophysiology and Live Cell Nucleus Labeling. Whole-cell patch recordings from cells in the brain slice were carried out with the aid of markers to identify NG2 cells and dividing cells. NG2 cells were identified by loading Alexa Fluor 568/594 with recording pipette as previously described (11, 26). Sometimes, NG2 cells were identified by DsRed fluorescence by using NG2DsRedBAC mice as described (8). For nuclei labeling, slices were incubated with HO342 (Invitrogen) diluted to 2 μg/ml in articifical cerebrospinal fluid at RT for 30 min before recording and imaging. Recording pipettes were routinely filled with a solution containing 125 mM potassium gluconate, 15 mM KCl, 10 mM Hepes, 3 mM MgATP, 0.3 mM NaGTP, 5 mM sodium phosphocreatine, and 0.2 mM EGTA (pH 7.2–7.4, 290–300 mOsm). For INa recordings and synaptic currents in Fig. 5 Time-lapse Imaging of the Dividing Cells. Video recording of glial cells loaded with 100 μM Alexa Fluor 568/594 (Molecular Probes) through the recording pipette was obtained via a custom-made, 2-photon laser scanning microscopy. The details are described in previous studies (26). Cells were scanned with XYZ mode (1-μm Z step for each optical slice). Images were projected under the maximum through-depth contrast protocol in Image-Pro Plus5.0 (Media Cybernetics). Three-dimensional reconstruction was carried out by using 3D Constructor, a plug-in toolbox for IPP5.0. Supporting Information
Acknowledgments. We thank Dr. Akiko Nishiyama (Department of Physiology and Neurobiology, University of Connecticut) for providing the NG2DsRedBAC transgenic line; F. Huang, L.-J. Wu, W. Huang, and Y.-q. Zhu for critical reading of the manuscript; Y. Xiang, R. Yang, and B. Ye for critical comments on this work; S.-B. Yang for assistance with confocal imaging and genotyping; and Dr. S. Duan and members from Jan and Duan laboratories for valuable discussions. This work was supported by a National Institute of Mental Health grant, National Natural Science Foundation of China Grants 30700215 and 60025514, and National High-Tech Research and Development Program of China 863 Program 2006AA02Z343. Woo-Ping Ge was the recipient of a long-term fellowship of Human Frontier Science Program. Lily Yeh Jan and Yuh Nung Jan are Howard Hughes Medical Institute investigators. Footnotes The authors declare no conflict of interest. This article contains supporting information online at www.pnas.org/cgi/content/full/0811353106/DCSupplemental. References 1. Haydon PG. GLIA: Listening and talking to the synapse. Nat Rev Neurosci. 2001;2:185–193. [PubMed] 2. Levine JM, Card JP. Light and electron microscopic localization of a cell surface antigen (NG2) in the rat cerebellum: Association with smooth protoplasmic astrocytes. J Neurosci. 1987;7:2711–2720. [PubMed] 3. Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 1983;303:390–396. [PubMed] 4. Levine JM, Reynolds R, Fawcett JW. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 2001;24:39–47. [PubMed] 5. Schools GP, Zhou M, Kimelberg HK. Electrophysiologically “complex” glial cells freshly isolated from the hippocampus are immunopositive for the chondroitin sulfate proteoglycan NG2. J Neurosci Res. 2003;73:765–777. [PubMed] 6. Nishiyama A, Watanabe M, Yang Z, Bu J. Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J Neurocytol. 2002;31:437–455. [PubMed] 7. Stallcup WB. The NG2 antigen, a putative lineage marker: immunofluorescent localization in primary cultures of rat brain. Dev Biol. 1981;83:154–165. [PubMed] 8. Zhu X, Bergles DE, Nishiyama A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development. 2008;135:145–157. [PubMed] 9. Dawson MR, Polito A, Levine JM, Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci. 2003;24:476–488. [PubMed] 10. Bergles DE, Roberts JD, Somogyi P, Jahr CE. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature. 2000;405:187–191. [PubMed] 11. Ge WP, et al. Long-term potentiation of neuron-glia synapses mediated by Ca2+-permeable AMPA receptors. Science. 2006;312:1533–1537. [PubMed] 12. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci. 2007;10:321–330. [PubMed] 13. Kukley M, Capetillo-Zarate E, Dietrich D. Vesicular glutamate release from axons in white matter. Nat Neurosci. 2007;10:311–320. [PubMed] 14. Mangin JM, Kunze A, Chittajallu R, Gallo V. Satellite NG2 progenitor cells share common glutamatergic inputs with associated interneurons in the mouse dentate gyrus. J Neurosci. 2008;28:7610–7623. [PubMed] 15. Bliss TV, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature. 1993;361:31–39. [PubMed] 16. Butt AM, et al. Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter. Glia. 1999;26:84–91. [PubMed] 17. Wigley R, Hamilton N, Nishiyama A, Kirchhoff F, Butt AM. Morphological and physiological interactions of NG2-glia with astrocytes and neurons. J Anat. 2007;210:661–670. [PubMed] 18. Butt AM, Hamilton N, Hubbard P, Pugh M, Ibrahim M. Synantocytes: The fifth element. J Anat. 2005;207:695–706. [PubMed] 19. Nishiyama A. Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist. 2007;13:62–76. [PubMed] 20. Horner PJ, et al. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci. 2000;20:2218–2228. [PubMed] 21. Ajioka I, et al. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell. 2007;131:378–390. [PubMed] 22. Levison SW, Goldman JE. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron. 1993;10:201–212. [PubMed] 23. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci. 2002;22:629–634. [PubMed] 24. Polito A, Reynolds R. NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat. 2005;207:707–716. [PubMed] 25. Dawson MR, Levine JM, Reynolds R. NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors? J Neurosci Res. 2000;61:471–479. [PubMed] 26. Zhou W, Ge WP, Zeng S, Duan S, Luo Q. Identification and two-photon imaging of oligodendrocyte in CA1 region of hippocampal slices. Biochem Biophys Res Commun. 2007;352:598–602. [PubMed] 27. Chittajallu R, Aguirre A, Gallo V. NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J Physiol. 2004;561:109–122. [PubMed] 28. Káradóttir R, Hamilton NB, Bakiri Y, Attwell D. Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Nat Neurosci. 2008;11:450–456. [PubMed] 29. Lin SC, Bergles DE. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat Neurosci. 2004;7:24–32. [PubMed] 30. Kukley M, et al. Glial cells are born with synapses. FASEB J. 2008;22:2957–2969. [PubMed] 31. Wren D, Wolswijk G, Noble M. In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells. J Cell Biol. 1992;116:167–176. [PubMed] 32. Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci. 2001;21:2661–2668. [PubMed] 33. Fischer AJ, McGuire CR, Dierks BD, Reh TA. Insulin and fibroblast growth factor 2 activate a neurogenic program in Muller glia of the chicken retina. J Neurosci. 2002;22:9387–9398. [PubMed] 34. Ichimura K, Schmidt EE, Goike HM, Collins VP. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene. 1996;13:1065–1072. [PubMed] 35. Barres BA, Raff MC. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature. 1993;361:258–260. [PubMed] 36. Canoll PD, et al. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron. 1996;17:229–243. [PubMed] 37. Verkhratsky A, Orkand RK, Kettenmann H. Glial calcium: Homeostasis and signaling function. Physiol Rev. 1998;78:99–141. [PubMed] 38. Jan YN, Jan LY. Asymmetric cell division. Nature. 1998;392:775–778. [PubMed] 39. Temple S, Raff MC. Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell. 1986;44:773–779. [PubMed] 40. Levison SW, Young GM, Goldman JE. Cycling cells in the adult rat neocortex preferentially generate oligodendroglia. J Neurosci Res. 1999;57:435–446. [PubMed] 41. Rivers LE, et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci. 2008;11:1392–1401. [PubMed] 42. Ge WP, Duan S. Persistent enhancement of neuron-glia signaling mediated by increased extracellular K+ accompanying long-term synaptic potentiation. J Neurophysiol. 2007;97:2564–2569. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Nat Rev Neurosci. 2001 Mar; 2(3):185-93.
[Nat Rev Neurosci. 2001]J Neurosci. 1987 Sep; 7(9):2711-20.
[J Neurosci. 1987]Nature. 1983 Jun 2-8; 303(5916):390-6.
[Nature. 1983]Trends Neurosci. 2001 Jan; 24(1):39-47.
[Trends Neurosci. 2001]J Neurosci Res. 2003 Sep 15; 73(6):765-77.
[J Neurosci Res. 2003]Mol Cell Neurosci. 2003 Oct; 24(2):476-88.
[Mol Cell Neurosci. 2003]J Neurosci. 2000 Mar 15; 20(6):2218-28.
[J Neurosci. 2000]Cell. 2007 Oct 19; 131(2):378-90.
[Cell. 2007]Trends Neurosci. 2001 Jan; 24(1):39-47.
[Trends Neurosci. 2001]Neuron. 1993 Feb; 10(2):201-12.
[Neuron. 1993]J Neurosci. 2002 Feb 1; 22(3):629-34.
[J Neurosci. 2002]J Anat. 2005 Dec; 207(6):707-16.
[J Anat. 2005]J Neurosci Res. 2000 Sep 1; 61(5):471-9.
[J Neurosci Res. 2000]Biochem Biophys Res Commun. 2007 Jan 19; 352(3):598-602.
[Biochem Biophys Res Commun. 2007]Science. 2006 Jun 9; 312(5779):1533-7.
[Science. 2006]Development. 2008 Jan; 135(1):145-57.
[Development. 2008]J Physiol. 2004 Nov 15; 561(Pt 1):109-22.
[J Physiol. 2004]Nat Neurosci. 2008 Apr; 11(4):450-6.
[Nat Neurosci. 2008]Nature. 2000 May 11; 405(6783):187-91.
[Nature. 2000]Science. 2006 Jun 9; 312(5779):1533-7.
[Science. 2006]Nat Neurosci. 2007 Mar; 10(3):321-30.
[Nat Neurosci. 2007]Nat Neurosci. 2007 Mar; 10(3):311-20.
[Nat Neurosci. 2007]J Neurosci. 2008 Jul 23; 28(30):7610-23.
[J Neurosci. 2008]Nat Neurosci. 2004 Jan; 7(1):24-32.
[Nat Neurosci. 2004]FASEB J. 2008 Aug; 22(8):2957-69.
[FASEB J. 2008]Nature. 2000 May 11; 405(6783):187-91.
[Nature. 2000]Science. 2006 Jun 9; 312(5779):1533-7.
[Science. 2006]J Neurosci Res. 2000 Sep 1; 61(5):471-9.
[J Neurosci Res. 2000]J Cell Biol. 1992 Jan; 116(1):167-76.
[J Cell Biol. 1992]FASEB J. 2008 Aug; 22(8):2957-69.
[FASEB J. 2008]J Neurosci. 2001 Apr 15; 21(8):2661-8.
[J Neurosci. 2001]J Neurosci. 2002 Nov 1; 22(21):9387-98.
[J Neurosci. 2002]Cell. 2007 Oct 19; 131(2):378-90.
[Cell. 2007]FASEB J. 2008 Aug; 22(8):2957-69.
[FASEB J. 2008]Oncogene. 1996 Sep 5; 13(5):1065-72.
[Oncogene. 1996]Nature. 1993 Jan 21; 361(6409):258-60.
[Nature. 1993]Neuron. 1996 Aug; 17(2):229-43.
[Neuron. 1996]Nature. 2000 May 11; 405(6783):187-91.
[Nature. 2000]Science. 2006 Jun 9; 312(5779):1533-7.
[Science. 2006]Nat Neurosci. 2007 Mar; 10(3):321-30.
[Nat Neurosci. 2007]Nature. 1998 Apr 23; 392(6678):775-8.
[Nature. 1998]J Cell Biol. 1992 Jan; 116(1):167-76.
[J Cell Biol. 1992]Cell. 1986 Mar 14; 44(5):773-9.
[Cell. 1986]Mol Cell Neurosci. 2003 Oct; 24(2):476-88.
[Mol Cell Neurosci. 2003]J Neurosci Res. 1999 Aug 15; 57(4):435-46.
[J Neurosci Res. 1999]J Neurosci Res. 2000 Sep 1; 61(5):471-9.
[J Neurosci Res. 2000]Science. 2006 Jun 9; 312(5779):1533-7.
[Science. 2006]J Neurophysiol. 2007 Mar; 97(3):2564-9.
[J Neurophysiol. 2007]Science. 2006 Jun 9; 312(5779):1533-7.
[Science. 2006]Biochem Biophys Res Commun. 2007 Jan 19; 352(3):598-602.
[Biochem Biophys Res Commun. 2007]Development. 2008 Jan; 135(1):145-57.
[Development. 2008]Biochem Biophys Res Commun. 2007 Jan 19; 352(3):598-602.
[Biochem Biophys Res Commun. 2007]